New Schizophrenia Treatments Address Unmet Clinical Needs.
Year: 2017
Type: article
Abstract: We present several novel drugs in development for enhancing cognition, treating negative symptoms, and providing improved options for treatment-resistant patients. Drug makers aim to enhance safety profiles and increase patient compliance to therapy.
Source: Europe PMC (PubMed Central)
Author: Chris Fellner
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2980544089
